References
- 1. Ungprasert P, Ryu JH, Matteson EL. Clinical manifestations, diagnosis, and treatment of sarcoidosis. Mayo Clinic Proceedings: Innovations, Quality & Outcomes. 2019;3(3): 358–375. doi: 10.1016/j.mayocpiqo.2019.04.006.10.1016/j.mayocpiqo.2019.04.006671383931485575
- 2. Rao DA, Dellaripa PF. Extrapulmonary manifestations of sarcoidosis. Rheumatic Disease Clinics of North America. 2013;39(2): 277–297. doi: 10.1016/j.rdc.2013.02.007.10.1016/j.rdc.2013.02.007375666723597964
- 3. Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. New England Journal of Medicine. 2007;357(21): 2153–2165. doi: 10.1056/NEJMra071714.10.1056/NEJMra07171418032765
- 4. Schilstra A, Rottoli P, Jacobs JA, van Suylen RJ, Galluzzi P, Drent M. Case studies to explore the pitfalls in the diagnosis of sarcoidosis. Sarcoidosis Vasculitis and Diffuse Lung Diseases. 2006;23(2): 135–140.
- 5. Lacomis D. Neurosarcoidosis. Current Neuropharmacology. 2011;9(3): 429–436. doi: 10.2174/157015911796557975.10.2174/157015911796557975315159722379457
- 6. Haimovic A, Sanchez M, Judson MA, Prystowsky S. Sarcoidosis: a comprehensive review and update for the dermatologist: part I. Cutaneous disease. Journal of the American Academy of Dermatology. 2012;66: 699.e1–699.e18.10.1016/j.jaad.2011.11.96522507585
- 7. Herbort CP, Rao NA, Mochizuki M; Members of Scientific Committee of First International Workshop on Ocular Sarcoidosis. International criteria for the diagnosis of ocular sarcoidosis: results of the first International Workshop on Ocular Sarcoidosis (IWOS). Ocular Immunology and Inflammation. 2009;17(3): 160–169.10.1080/0927394090281886119585358
- 8. Mota PC, Morais A, Palmares C, Beltrão M, Melo N, Santos AC. Diagnostic value of CD103 expression in bronchoalveolar lymphocytes in sarcoidosis. Respiratory Medicine. 2012;106(7): 1014–1020.10.1016/j.rmed.2012.03.02022537923
- 9. Saidha S, Sotirchos ES, Eckstein C. Etiology of sarcoidosis: does infection play a role? Yale Journal of Biology and Medicine. 2012;85(1): 133–141.
- 10. Ogisu N, Sato S, Kawaguchi H, Sugiura Y, Mori T, Niimi T. Elevated level of soluble HLA class I antigens in serum and bronchoalveolar lavage fluid in patients with sarcoidosis. Internal Medicine. 2001;40(3): 201–207.10.2169/internalmedicine.40.20111310485
- 11. Crouser ED, Maier LA, Wilson KC, Bonham CA, Morgenthau AS, Patterson KC, et al. Diagnosis and detection of sarcoidosis. An official American Thoracic Society clinical practice guideline. American Journal of Respiratory and Critical Care Medicine. 2020;201(8): 26–51. doi: 10.1164/rccm.202002-0251ST.10.1164/rccm.202002-0251ST715943332293205
- 12. Sehgal IS, Dhooria S, Aggarwal AN, Behera D, Agarwal R. Endosonography versus mediastinoscopy in mediastinal staging of lung cancer: systematic review and meta-analysis. Annals of Thoracic Surgery. 2016;102: 1747–1755.10.1016/j.athoracsur.2016.05.11027637288
- 13. Fritscher-Ravens A, Sriram PV, Topalidis T, Hauber HP, Meyer A, Soehendra N, et al. Diagnosing sarcoidosis using endosonography-guided fine-needle aspiration. Chest. 2000;118(4): 928–935. doi: 10.1378/chest.118.4.928. PMID: 11035658.10.1378/chest.118.4.92811035658
- 14. Judson MA. Advances in the diagnosis and treatment of sarcoidosis. F1000Prime Reports. 2014;6: 89. doi: 10.12703/P6-89.10.12703/P6-89419127125374667
- 15. Valeyre D, Bernaudin JF, Uzunhan Y, Kambouchner M, Brillet PY, Soussan M, et al. Clinical presentation of sarcoidosis and diagnostic work-up. Seminars in Respiratory and Critical Care Medicine. 2014;35(3): 336–351. doi: 10.1055/s-0034-1381229.10.1055/s-0034-138122925007086
- 16. Li CW, Tao RJ, Zou DF, Li MH, Xu X, Cao WJ. Pulmonary sarcoidosis with and without extrapulmonary involvement: a cross-sectional and observational study in China. BMJ Open. 2018;8: e18865. doi: 10.1136/bmjopen-2017-018865.10.1136/bmjopen-2017-018865582977929453299
- 17. Prosch H, Vonbank K, Loewe C, Beitzke D. Die vielen Gesichter der Sarkoidose. Der Radiologe. 2016;56(1): 77–89. doi: 10.1007/s00117-015-0063-9.10.1007/s00117-015-0063-926732655
- 18. Lee HN, Kim JI, Won K, Song R. Atypical CT findings of pulmonary sarcoidosis: A case report. Medicine (Baltimore). 2018;97(29): e11456. doi: 10.1097/MD.0000000000011456.10.1097/MD.0000000000011456608652330024519
- 19. Valeyre D, Bernaudin, JF, Jeny F, Duchemann B, Freynet O, Planès C, et al. Pulmonary sarcoidosis. Clinics in Chest Medicine 2015;36(4): 631–641.10.1016/j.ccm.2015.08.00626593138
- 20. Dziedzic DA, Peryt A, Orlowski T. The role of EBUS-TBNA and standard bronchoscopic modalities in the diagnosis of sarcoidosis. Clinical Respiratory Journal. 2017;11(1): 58–63. doi: 10.1111/crj.12304.10.1111/crj.1230425919969
- 21. Chapman S, Robinson G, Strandling J, West S, Wrightson J. Oxford Handbook of Respiratory Medicine. 3rd ed. United States of America: Oxford University Press; 2014.10.1093/med/9780198703860.003.0001
- 22. Carmona EM, Kalra S, Ryu JH. Pulmonary sarcoidosis: diagnosis and treatment. Mayo Clinic Proceedings. 2016:91(7): 946–954.10.1016/j.mayocp.2016.03.00427378039
- 23. Patel A, Bahna SL. Immediate hypersensitivity reactions to corticosteroids. Annals of Allergy, Asthma & Immunology. 2015:115(3): 178–182.10.1016/j.anai.2015.06.022
- 24. Baughman RP, Lower EE. A clinical approach to the use of methotrexate for sarcoidosis. Thorax 1999;54: 742–746.10.1136/thx.54.8.742
- 25. Vorselaars ADM, Wuyts WA, Vorselaars VMM, Zanen P, Deneer VHM, Veltkamp M. Methotrexate vs azathioprine in second-line therapy of sarcoidosis. Chest. 2013:144(3): 805–812. doi: 10.1378/chest.12-1728.10.1378/chest.12-1728
- 26. Beegle SH, Barba K, Gobunsuy R, Judson MA. Current and emerging pharmacological treatments for sarcoidosis: a review. Drug Design, Development and Therapy. 2013;7: 325–338. doi: 10.2147/DDDT.S31064.10.2147/DDDT.S31064
- 27. Popescu NA, Sheehan MG, Kouides PA, Loughner JE, Condemi JJ, Looney RJ, et al. Allergic reactions to cyclophosphamide: Delayed clinical expression associated with positive immediate skin tests to drug metabolites in five patients. Journal of Allergy and Clinical Immunology, 1996:97(1): 26–33. doi: 10.1016/s0091-6749(96)70279-8.10.1016/S0091-6749(96)70279-8
- 28. Boleto G, Vieira M, Desbois AC, Saadoun D, Cacoub P. Emerging molecular targets for the treatment of refractory sarcoidosis. Frontiers in Medicine, 2020:7: 594133. doi: 10.3389/fmed.2020.594133.10.3389/fmed.2020.594133773255233330556
- 29. Crommelin HA, Vorselaars AD, van Moorsel CH, Korenromp IH, Deneer VH, Grutters JC. Anti-TNF therapeutics for the treatment of sarcoidosis. Immunotherapy. 2014;6(10): 1127–1143. doi: 10.2217/imt.14.65.10.2217/imt.14.6525428650